Rich Pharmaceuticals Announces Submission of Investigational New Drug (IND) Application to FDA for the Treatment of Acute Myelocytic Leukemia and Myelodysplastic Syndrome
October 23, 2014 07:00 ET
|
Rich Pharmaceuticals, Inc.
BEVERLY HILLS, Calif., Oct. 23, 2014 (GLOBE NEWSWIRE) -- Rich Pharmaceuticals, Inc. (OTCQB:RCHA) ("Rich" or the "Company"), a clinical-stage biotechnology company focused on developing innovative...
Rich Pharmaceuticals Announces Assignment Agreement Acquiring Complete Ownership, Development and Commercialization Rights for Indication, Patents and Intellectual Property Related to the Treatment of Hodgkin's Lymphoma
October 13, 2014 09:30 ET
|
Rich Pharmaceuticals, Inc.
BEVERLY HILLS, Calif., Oct. 13, 2014 (GLOBE NEWSWIRE) -- Rich Pharmaceuticals, Inc. (OTCQB:RCHA) ("Rich" or the "Company") Rich, a cancer therapeutics development company announced that it has entered...
Rich Pharmaceuticals Announces Up to $4.5 Million Finance Deal to Fund Phase 2 Clinical Trials in Acute Myelocytic Leukemia
October 09, 2014 07:00 ET
|
Rich Pharmaceuticals, Inc.
BEVERLY HILLS, Calif., Oct. 9, 2014 (GLOBE NEWSWIRE) -- Rich Pharmaceuticals, Inc. (OTCQB:RCHA) ("Rich" or the "Company") Rich, a cancer therapeutics development company announced that it has entered...
Rich Pharmaceuticals Hires Contract Research Organization to File NDA and Identify Clinical Trial Site(s) for Lead Compound
July 23, 2014 07:00 ET
|
Rich Pharmaceuticals, Inc.
BEVERLY HILLS, Calif., July 23, 2014 (GLOBE NEWSWIRE) -- Rich Pharmaceuticals, Inc. (OTCQB:RCHA) ("Rich" or the "Company") announced the company has hired San Diego, CA based contract research...
Rich Pharmaceuticals Appoints Dr. Chieanchuang Kalayanamitr to Medical Advisory Board
May 06, 2014 11:09 ET
|
Rich Pharmaceuticals, Inc.
BEVERLY HILLS, Calif., May 6, 2014 (GLOBE NEWSWIRE) -- Rich Pharmaceuticals, Inc. (OTCQB:RCHA) ("Rich" or the "Company") is pleased to announce the appointment of Dr. Chieanchuang Kalayanamitr to the...
Rich Pharmaceuticals Provides Financing Update
April 30, 2014 07:00 ET
|
Rich Pharmaceuticals, Inc.
BEVERLY HILLS, Calif., April 30, 2014 (GLOBE NEWSWIRE) -- Rich Pharmaceuticals, Inc. (OTCQB:RCHA) ("Rich" or the "Company") is pleased to announce the completion of additional financing of...
Rich Pharmaceuticals Appoints Professor Richard L. Chang to Medical Advisory Board
April 17, 2014 09:00 ET
|
Rich Pharmaceuticals, Inc.
BEVERLY HILLS, Calif., April 17, 2014 (GLOBE NEWSWIRE) -- Rich Pharmaceuticals, Inc. (OTCQB:RCHA) ("Rich" or the "Company") is pleased to announce the appointment of Professor Richard L. Chang to the...
Rich Pharmaceuticals Warns Investors of Unauthorized Spam Stock Promotion
April 14, 2014 07:00 ET
|
Rich Pharmaceuticals, Inc.
BEVERLY HILLS, Calif., April 14, 2014 (GLOBE NEWSWIRE) -- Rich Pharmaceuticals, Inc. (OTCQB:RCHA) ("Rich" or the "Company"), has been made aware of a recent spam stock promotion regarding shares of...
Rich Pharmaceuticals Appoints Renping Zhou, Ph.D., to Medical Advisory Board
April 08, 2014 07:00 ET
|
Rich Pharmaceuticals, Inc.
BEVERLY HILLS, Calif., April 8, 2014 (GLOBE NEWSWIRE) -- Rich Pharmaceuticals, Inc. (OTCQB:RCHA) ("Rich" or the "Company") is pleased to announce the appointment of Renping Zhou, Ph.D., to the...
Rich Pharmaceuticals Appoints Dr. McCoy L. Moretz to Medical Advisory Board
March 19, 2014 09:00 ET
|
Rich Pharmaceuticals, Inc.
BEVERLY HILLS, Calif., March 19, 2014 (GLOBE NEWSWIRE) -- Rich Pharmaceuticals, Inc. (OTCQB:RCHA) ("Rich" or the "Company") is pleased to announce the appointment of Dr. McCoy L. Moretz to the...